Ampronix introduces Chromamaxx LCD line

TriMed Staff | | Health Imaging | Screening
Ampronix Inc. has introduced the Chromamaxx Color LCD (liquid crystal display) flat- panel display line.  
           
The Irvine, Calif.-based distributor said the Chromamaxx series of color flat-panel displays offers 'Any Signal, Any Input' and is a universal platform for viewing images from a wide range of signals and inputs available to the medical industry.  
           
Models are available in 15-inch, 17-inch and 21-inch with input configurations including: RGB BNC; DVI-D; DVI-A; 13W3; Composite Video; S video; and even a 15 pin D sub offered on the 15-inch display.  
           
The entire family of Chromamaxx panels have sync on Green capabilities and offer a range of compatibility from low frequency to high frequency. The displays are available in three different colors.

TriMed Staff

Related Content

Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.